1. Wilson PG, Manji M, Neoptolemos JP. Acute pancreatitis as a model of sepsis. J Antimicrob Chemother 1998; 41(SupplA): 51–63.
2. Bhatnagar A, Wig JD, Majumdar S. Immunological findings in acute and chronic pancreatitis. ANZ J Surg 2003; 73: 59–64.
3. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007; 81: 1–5.
4. Dugernier TL, Laterre PF, Wittebole X et al.Compartmentalization of the inflammatory response during acute pancreatitis: correlation with local and systemic complications. Am J Respir Crit Care Med 2003; 168: 148–57.
5. Kylanpaa-Back ML, Takala A, Kemppainen E et al. Cellular markers of systemic inflammation and immune suppression in patients with organ failure due to severe acute pancreatitis. Scand J Gastroenterol 2001; 36: 1100–7.
6. Larvin M, Alexander DJ, Switala SF, McMahon MJ. Impaired mononuclear phagocyte fuction in patients with severe acute pancreatitis: evidence from studies of plasma clearance of trypsin and monocyte phagocytosis. Dig Dis Sci 1993; 38: 18–27.
7. Сотченко Б.А., Сапиенко С.В. Возможности прогнозирования течения острого деструктивного панкреатита на основании динамики показателей цитокинового статуса. Анн. хир. гепатол. 2008; 13(3): 71.
8. Sakai Y, Masamune A, Satoh A et al. Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis. Gastroenterology 2003; 124: 725–36.
9. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol 1988; 3: 105–12.
10. Gukovskaya AS, Gukovsky I, Zaninovic V et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factoralpha. Role in regulating cell death and pancreatitis. J Clin Invest 1997; 100: 1853–62.
11. Fisher CJ Jr, Dhainaut JF, Opal SM et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA 1994; 271: 1836–43.
12. Grewal HP, Mohey ED, Gaber L et al. Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-alpha polyclonal antibody. Am J Surg 1994; 167: 214–8.
13. Norman JG, Franz MG, Fink GS et al. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade. Ann Surg 1995; 221: 625–31.
14. Bhatia M. Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome. Curr Drug Targets Inflamm Allergy 2002; 1: 343–51.
15. Seitz M, Loetscher P, Dewald B et al. Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fi broblasts. Eur J Immunol 1995; 25: 1129–32.
16. Dembinski A, Warzecha Z, Ceranowicz P et al. Pancreatic damage and regeneration in the course of ischemiareperfusion induced pancreatitis in rats. J Physiol Pharmacol 2001; 52: 221–35.
17. Norman JG, Fink GW, Franz MG. Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 1995; 130: 966–70.
18. Dumot JA, Conwell DL, Zuccaro G Jr, et al. Randomized, double blind study of interleukin 10 for the prevention of ERCPinduced pancreatitis. Am J Gastroenterol 2001; 96: 2098–102.
19. Deviere J, Le Moine O, Van Laethem JL et al. Interleukin-10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001; 120: 498–505.
20. Formela LJ, Wood LM, Whittaker M, Kingsnorth AN. Amelioration of experimental acute pancreatitis with a potent plateletactivating factor antagonist. Br J Surg 1994; 81: 1783–5.
21. McKay CJ, Curran F, Sharples C et al. Prospective placebocontrolled randomized trial of lexipafant in predicted severe acute pancreatitis. Br J Surg 1997; 84: 1239–43.
22. Rongione AJ, Kusske AM, Reber HA et al. Interleukin-10 reduces circulating levels of serum cytokines in experimental pancreatitis. J Gastrointest Surg 1997; 1: 159–66.
23. Rongione AJ, Kusske AM, Kwan K et al. Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology 1997; 112: 960–7.
24. Osman MO, Jacobsen NO, Kristensen JU et al. IT 9302, a synthetic interleukin-10 agonist, diminishes acute lung injury in rabbits with acute necrotizing pancreatitis. Surgery 1998; 124: 584–92.
1 Кафедра хирургии и 2кафедра иммунологии медико-биологического факультета Российского государственного медицинского университета им. Н.И.Пирогова, Москва